Conference Highlights

Friday, November 12, 2010

07:30-08:30	Workshop on Clinical Trial Design - John A "Drew" Ridge		Presentation (pdf)
08:50-09:00	Welcome - Jim Bonner		Presentation (pdf)
9:00-09:50	Opening keynote lecture (moderator: Jim Bonner)
	HPV-associated cancers on the rise, a growing problem? - Margaret Stanley	Abstract (pdf)	Presentation (pdf)
09:50-10:20	Coffee break
10:20-12:00	Joint session (moderator: Margaret Stanley)
	HPV vaccines: current issues in HPV-associated cancers
10:20	Screening women vaccinated for HPV16/18 - Jack Cuzick	Abstract (pdf)	Presentation (pdf)
10:45	Vaccination for boys: the paediatrician's perspective - Hal Jenson	Abstract (pdf)	Presentation (pdf)
11:10	Community randomised Phase IV HPV vaccination effectiveness trial: Baseline characteristics and trial deliverables - Matti Lehtinen	Abstract (pdf)	Presentation (pdf)
11:35	Vaccine development in the developing world - John Sellors	Abstract (pdf)	Presentation (pdf)
12:00	Session ends
12:00-13:30	Lunch break
13:30-15:10	Parallel session (moderator: Chris Meijer)
	Risk assessment and treatment in cervical cancer
13:30	Management of screen-detected HPV-positive women- Guglielmo Ronco	Abstract (pdf)	Presentation (pdf)
13:55	Risk of high-grade CIN in women with HPV infection: role of persistence and genotyping - Nicolas Wentzensen	Abstract (pdf)	Presentation (pdf)
14:20	Organisation of HPV-based screening - Ahti Anttila	Abstract (pdf)	Presentation (pdf)
14:45	Age issues in HPV screening - Guglielmo Ronco	Abstract (pdf)	Presentation (pdf)
15:10	Session ends
13:30-15:10	Parallel session (moderator: Maura Gillison)
	New agents in head and neck cancer
13:30	HPV and incidence trends for head and neck cancer - Anil Chaturvedi	Abstract (pdf)	Presentation (pdf)
13:55	The new era of targeted agents in head and neck cancer - Jim Bonner	Abstract (pdf)	Presentation (pdf)
14:20	Side effects of the new targeted agents in head and neck cancer - Jean Pierre Armand	Abstract (pdf)	Presentation (pdf)
14:45	Critical assessment of the role of chemotherapy, surgery, and radiation therapy in HPV-related oropharyngeal cancer and future clinical trials - Marshall Posner	Abstract (pdf)	Presentation (pdf)
15:10	Session ends
15:10-15:40	Tea break
15:40-17:20	Joint session (moderator: Marshall Posner)
	Clinical trial design in relation to HPV-associated disease
15:40	HPV and clinical trial design for head and neck cancer - Maura Gillison	Abstract (pdf)	Presentation (pdf)
16:05	The importance of window of opportunity studies - Jan Vermorken
16:30	Long-term efficacy of HPV vaccination against hard end-points: Cancer registry based follow-up of phase III efficacy trials - Jorma Paavonen	Abstract (pdf)	Presentation (pdf)
16:55	Ecological competition of vaccine-type and non-vaccine-type HPVs before and after mass vaccination - Matti Lehtinen	Abstract (pdf)	Presentation (pdf)
17:20	Session ends
17:20	End of day

Saturday, November 13, 2010

9:00-10:40	Parallel session (moderator: Jorma Paavonen)
	HPV testing, translational research, and the clinic
09:00	HPV testing in the developing world - John Sellors	Abstract (pdf)	Presentation (pdf)
09:25	Use of biomarkers in HPV screening programmes - Nicolas Wentzensen	Abstract (pdf)	Presentation (pdf)
09:50	Is HPV prognostic, predictive, or both? - Lisa Licitra	Abstract (pdf)	Presentation (pdf)
10:15	Therapeutic HPV vaccines - Cornelia Trimble	Abstract (pdf)
10:40	Session ends
9:00-10:40	Parallel session (moderator: Jens Overgaard)
	Management of mouth and oral-pharyngeal cancers in relation to HPV
09:00	Prevalence, natural history, and transmission of oral HPV in relation to oropharyngeal cancer- Gypsyamber Dsouza	Abstract (pdf)
09:25	HPV-specific genetic markers in HPV-associated head and neck and cervical cancers- Peter Snijders	Abstract (pdf)
09:50	Neck dissection in the surgical management of oropharyngeal cancer: controversies and outstanding questions - Ian Martin	Abstract (pdf)	Presentation (pdf)
10:15	Evolving treatment paradigms in the management of oropharyngeal cancer - Maura Gillison		Presentation (pdf)
10:40	Session ends
10:40-11:10	Coffee break
11:10-12:25	Joint session (moderator: Joel Palefsky)
	Genetics, environment, and lifestyle factors
11:10	HPV infection in pregnancy: issues in relation to prophylactic and therapeutic strategies - Jorma Paavonen	Abstract (pdf)	Presentation (pdf)
11:35	Co-morbidity and smoking behaviour in HPV positive and negative HNSCC patients in relation to outcome - Jens Overgaard
12:00	Race and ethnicity in HPV-related oropharyngeal cancer - Kevin Cullen	Abstract (pdf)	Presentation (pdf)
12:25	Session ends
12:25-14:00	Lunch break
14:00-15:15	Parallel session (moderator: Guglielmo Ronco)
	Penile and anal cancers: biology and current management
14:00	Prevention and treatment approaches to AIN and anal cancer - Joel Palefsky	Abstract (pdf)	Presentation (pdf)
14:25	Prophylactic vaccines for anogenital cancer - Margaret Stanley		Presentation (pdf)
14:50	Circumcision for prevention of ano-genital and oral cancers? - Tim Oliver	Abstract (pdf)	Presentation (pdf)
15:15	Session ends
14:00-15:15	Parallel session (moderator: Jean Pierre Armand)
	Radiation in HPV-infected head and neck and oral-pharyngeal cancers
14:00	Radiation in HPV-infected head and neck and oral pharyngeal cancers - Pernille Lassen	Abstract (pdf)	Presentation (pdf)
14:25	Rationale for radiation dose reduction in HPV-related oropharyngeal cancer - Marshall Posner	Abstract (pdf)	Presentation (pdf)
14:50	Hypoxia, HPV, and radiotherapy: interactions and implications for outcome - Jens Overgaard
15:15	Session ends
15:20-16:10	Closing keynote lecture (moderator: Jim Bonner)
	HPV infection in the HIV-positive host: molecular interactions and clinical implications - Joel Palefsky	Abstract (pdf)	Presentation (pdf)
16:10-16:20	Closing remarks - Jim Bonner		Presentation (pdf)